Latest Headlines

  1. numares And Bruker Sign Agreement To Enable Advanced Metabolomics-Based Clinical Diagnostics 1/21/2021

    Leading metabolomics based diagnostics company numares AG and analytical instrumentation and solution provider Bruker Corporation have signed an agreement to collaborate to bring new diagnostics tests utilizing NMR to the laboratory market for unmet medical needs.

  2. OraSure’s Oragene®•Dx Saliva Collection Kit Included In Industry’s First FDA Authorization For A Whole Exome Sequencing Platform 1/21/2021

    OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-care diagnostic tests, specimen collection devices, and microbiome laboratory and analytical services, today announced that its Oragene®•Dx (OGD-610) saliva collection device was included as a component in the De Novo authorization granted by the U.S. Food & Drug Administration (FDA) to Helix for their Helix® Laboratory Platform, a whole exome sequencing platform.

  3. Aiforia Partners With Pathan To Bring Artificial Intelligence Assisted Diagnostics To The Pathology Lab 1/21/2021

    Pathan, one of the largest pathology laboratories in the Netherlands, has started a collaboration with Aiforia, a leading software company providing artificial intelligence (AI) solutions for medical image analysis.

  4. Automation-Ready Sample Evaporator For Microplates 1/21/2021

    Porvair Sciences has launched a new second generation model of its Ultravap Mistral - an automation-ready sample evaporator that offers throughput advantages to laboratories looking to optimise and accelerate sample preparation.

  5. Rapid, Cost-Efficient Sample Processing In Workflows Such As COVID-19 Testing Enabled Through Hamilton Storage And Rhinostics Partnership 1/19/2021

    Hamilton Storage and Rhinostics, an early-stage Harvard University spin-out company, are pleased to announce the first step in a collaboration to improve decapping and accessioning of patient samples. These common bottlenecks occur during clinical sample processing of assays to detect antibodies and antigens in relation to the novel coronavirus, SARS-CoV-2, as well as many other pathogens.

  6. IDT Developing PrimeTime SARS-CoV-2/Flu Test For Comprehensive Patient Testing 1/19/2021

    Integrated DNA Technologies (IDT), a leading comprehensive genomics solutions provider, is developing a multiplex RT-qPCR test that can detect and distinguish between SARS-CoV-2, influenza A, and influenza B from a single patient sample. The new PrimeTime SARS-CoV-2/Flu Test is being submitted by IDT for U.S. Food and Drug Administration Emergency Use Authorization (EUA).

  7. Applied DNA Linea COVID-19 Assay Kit Demonstrates Effectiveness With Detection Of Multiple SARS-CoV-2 Variants During Recent Surveillance Testing 1/19/2021

    Applied DNA Sciences, Inc.(the “Company”), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing, today announced that its Linea COVID-19 Assay Kit (the “Assay Kit”) identified COVID-19 positive samples that are variants distinct from the wild-type virus that has dominated the U.S. in the pandemic until now.

  8. PreventionGenetics Selected To Join Concert Genetics' Preferred Laboratory Network 1/19/2021

    With more than 150,000 genetic tests available, at least 6.9 codes per claim and thousands of medical policies1,2, it's virtually impossible for providers and payers to keep up with the complex and ever-changing world of genetic testing.

  9. Canadian Pathology Quality Assurance Leverages Diaceutics’ DXRX Platform To Advance NTRK IHC Proficiency Testing 1/18/2021

    Diaceutics PLC,today announces a strategic partnership with Canadian Pathology Quality Assurance (CPQA) to advance the development of Neurotrophic Tropomyosin Receptor Kinase (NTRK) IHC proficiency testing globally. This press release features multimedia.

  10. Eurobio Scientific Expands Its Range Of COVID-19 Tests With An Antigenic Rapid Test 1/18/2021

    Eurobio Scientific (FR0013240934, ALERS, PEA-PME eligible), a leading French group in in vitro medical diagnostics and life-sciences, today announces that its entire range of COVID-19 tests, that includes its new proprietary antigenic test for the detection of the SARS-CoV-2 antigen, is now fully referenced on the official website of the French Administration.